AbbVie Inc., announced a strategic collaboration with HotSpot Therapeutics Inc. to expand its immunology pipeline. This collaboration is estimated to lead to the development of the first and only small molecule inhibitor of IRF5 (interferon regulatory factor 5) intended for the treatment of autoimmune diseases using HotSpot's Smart Allostery drug discovery platform.
etectRx, to partner up with Pear Therapeutics, to make wireless sensors embedded in medications. Through the collaboration, both companies intend to develop further products combining medication adherence data with digital therapeutics.
Author Credits: Radhika Gupta, Shivam Bhutani